Linesol

Linezolid, the active ingredient in Linesol, is an oxazolidinone presented as an oral formulation for systemic use. It targets serious infections caused by resistant Gram‑positive bacteria, such as methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), and is indicated for adult patients with community‑acquired pneumonia and skin and soft‑tissue infections.

GNH USA supplies Linesol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation to facilitate import and distribution.

Linezolid is indicated for infections caused by resistant Gram‑positive bacteria and related respiratory and skin conditions.

- Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective bacterial eradication in skin, bloodstream and pulmonary sites. - Vancomycin‑resistant Enterococcus (VRE) infections: provides an alternative oral therapy for systemic disease. - Community‑acquired pneumonia: treats pneumonia caused by susceptible organisms, improving clinical outcomes. - Skin and soft‑tissue infections: resolves infections of the dermis and subcutaneous tissue caused by susceptible strains.

Linezolid may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools. - Headache: transient cranial discomfort. - Metallic taste: altered taste perception.

Serious or Rare Side Effects: - Thrombocytopenia: marked reduction in platelet count. - Peripheral neuropathy: nerve pain or sensory loss. - Optic neuritis: visual disturbances due to optic nerve inflammation. - Serotonin syndrome: risk when combined with serotonergic agents.

Precautions should be observed when prescribing Linezolid to ensure patient safety.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution and assess liver enzymes regularly. - Hematologic monitoring: perform baseline and periodic complete blood counts. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Pregnancy and lactation: assess risk–benefit before use. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Linezolid can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increased serotonergic effects. - Rifampicin: reduces linezolid plasma concentrations. - Erythromycin: may increase linezolid levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR. - Phenytoin: may lower linezolid exposure. - NSAIDs: additive hematologic effects.